Search Results 91-100 of 16762 for Azlocillin

  1. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  2. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving ...

  3. Mayo Clinic Drug Allergy Repository

    The purpose of this study is to build a Mayo Clinic registry of data and biobank from subjects with drug allergy. The data collected will include demographic, ...

  4. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    This study will assess the safety, tolerability, pharmaokinetics, and preliminary efficacy of mosunetuzumab (Lunsumio) monotherapy in participants with relapsed ...

  5. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving selinexor, carfilzomib, and dexamethasone may be ...

  6. Donepezil (transdermal route) - Side effects & dosage - Mayo Clinic

    Azlocillin; Bacampicillin; Baclofen; Bedaquiline. Show More. Using this medicine with any of the following medicines may cause an increased risk of certain side ...

  7. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

    The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of a single oral administration of study drug CP101 for the prevention of ...

  8. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    Inclusion Criteria: Diagnosis of Crohn's disease (CD) for at least 90 days, confirmed by endoscopy during the Screening Period.

  9. Naltrexone and bupropion (oral route) - Side effects & dosage - Mayo Clinic

    Azlocillin; Aztreonam; Bacampicillin; Baclofen; Balofloxacin; Belladonna Alkaloids; Benperidol; Benzhydrocodone; Benzphetamine; Bepotastine; Besifloxacin ...

  10. A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the impact of pitolisant on Excessive daytime sleepiness in patients with Prader-Willi syndrome. Participation ...